← Back to ENSC

Ensysce Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 15/05/2026Sep 2025Filed 14/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 15/05/2026Sep 2024Filed 14/11/2025Jun 2024Filed 13/08/2025Mar 2024Filed 13/05/2025
$1.2$1$0.5$1.4$1.3$3.4$0.2$0.3
−$2.6−$3.6−$3.7−$1.7−$1.9$0.7−$2−$3.1
−$0.20−$0.52−$1.29−$0.79−$1.39$1.00−$3.35−$8.21
136.82.92.21.40.60.4

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.